New research into malaria suggests targeting enzymes from the human host, rather than from the pathogen itself, could offer effective treatment for COVID-19, besides offering faster treatment for a range of many diseases. The international study, led by RMIT University’s Professor Christian Doerig, proposes a strategy that could save years of drug discovery research and millions of dollars in drug ...

Finally, a Covid-19 vaccine developed by Oxford University’s Jenner Institute and licensed to the multinational pharmaceutical company, AstraZeneca has emerged as the favourite of World Health Organization scientists out of about 23 vaccines in their Phase III trial, after reporting success and safety in the first two phases. For India, this vaccine is important as AstraZeneca, among others, had entered ...

Japan’s National Institute of Advanced Industrial Science and Technology (AIST) and IIT-Delhi joint research on Indian ayurvedic component Ashwagandha in combinaton with propolis, an actve ingredent from New Zealand can be developed as possible drug treatment to cure Coronavirus or COVID-19. The research by IIT-D was led by Professor D Sundar from DAILAB (DBT-AIST International Laboratory for Advanced Biomedicine) discovered ...